Probable epidemic Mycoplasma pneumoniae disease activity in metropolitan Sydney, 2015: combining surveillance data to cross-validate signal detection
DOI:
https://doi.org/10.33321/cdi.2017.41.40Keywords:
Mycoplasma pneumoniae, surveillance, encephalitis, pneumonia, children, AustraliaAbstract
Introduction
Mycoplasma pneumoniae is a leading cause of community acquired pneumonia and well-recognised cause of encephalitis in children. Sentinel hospital surveillance identified a temporal cluster of children with suspected encephalitis associated with M.pneumoniae in NSW. We aimed to determine whether this cluster was associated with epidemic M.pneumoniae activity.
Methods
A multi-faceted investigation was undertaken using existing data sources including:
Active clinical surveillance of suspected encephalitis (ACE study) associated with M.pneumoniae at the Children’s Hospital at Westmead (CHW).
Syndromic surveillance of Emergency Department presentations for pneumonia in children 0-16 years to 86 NSW hospitals.
Laboratory sentinel surveillance of M.pneumoniae testing performed at CHW and the Institute for Clinical Pathology and Medical Research (ICPMR), Westmead.
Results
We detected an increased number of cases of hospitalised suspected encephalitis associated with M. pneumoniae in 2015 at the Sydney Childrens Hospital Network (SCHN), with a peak in July, that were predominantly in Western Sydney. Concurrently, monthly pneumonia presentations to 86 NSW emergency departments in children aged 0-16 years increased in 2015. This increase was greater in children aged 5-16 years compared to those aged 0-4 years and in metropolitan sites compared with rural hospitals. Laboratory data from sentinel laboratories showed increased frequency of testing, and of tests returned positive for M.pneumoniae in 2015 compared to preceding years. In aggregate, this information was considered suggestive of epidemic activity of M.pneumoniae in metropolitan Sydney in 2015.
Conclusions
Active surveillance for childhood encephalitis has the potential to provide sentinel surveillance data to identify epidemic infectious disease activity. Combining multiple sources of surveillance data affords opportunities to cross-validate epidemic signals. M.pneumoniae disease activity is challenging to measure, and may be a cause of significant disease burden in Australian children during epidemic years.
Downloads
References
Christie LJ, Honarmand S, Talkington DF, Gavali SS, Preas C, Pan C-Y, et al. Pediatric encephalitis: what is the role of Mycoplasma pneumoniae? Pediatrics . 2007;120(2):305-13.
Bitnun A, Ford-Jones E, Blaser S, Richardson S. Mycoplasma pneumoniae ecephalitis. Seminars in pediatric infectious diseases. 2003;14(2):96-107. Epub 2003/07/26.
Atkinson TP, Waites KB. Mycoplasma pneumoniae Infections in Childhood. Pediatr Infect Dis J. 2014;33(1):92-4.
Meyer Sauteur PM, van Rossum AM, Vink C. Mycoplasma pneumoniae in children: carriage, pathogenesis, and antibiotic resistance. Curr Opin Infect Dis. 2014;27(3):220-7.
Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372(9):835-45.
Uldum SA, Bangsborg JM, Gahrn-Hansen B, Ljung R, Molvadgaard M, Fons Petersen R, et al. Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011. Euro Surveill. 2012;17(5):02.
Blystad H, Anestad G, Vestrheim DF, Madsen S, Ronning K. Increased incidence of Mycoplasma pneumoniae infection in Norway 2011. Euro Surveill. 2012;17(5):02.
Ferguson GD, Gadsby NJ, Henderson SS, Hardie A, Kalima P, Morris AC, et al. Clinical outcomes and macrolide resistance in Mycoplasma pneumoniae infection in Scotland, UK. Journal of medical microbiology . 2013;62(Pt 12):1876-82.
Linde A, Ternhag A, Torner A, Claesson B. Antibiotic prescriptions and laboratory-confirmed cases of Mycoplasma pneumoniae during the epidemic in Sweden in 2011. Euro Surveill. 2012;17(6).
Nir-Paz R, Abutbul A, Moses AE, Block C, Hidalgo-Grass C. Ongoing epidemic of Mycoplasma pneumoniae infection in Jerusalem, Israel, 2010 to 2012. Euro Surveill. 2012;17(8).
Glaser CA, Honarmand S, Anderson LJ, Schnurr DP, Forghani B, Cossen CK, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis. 2006;43(12):1565-77.
Pillai SC, Hacohen Y, Tantsis E, Prelog K, Merheb V, Kesson A, et al. Infectious and autoantibody-associated encephalitis: clinical features and long-term outcome. Pediatrics. 2015;135(4):e974-84.
Domenech C, Leveque N, Lina B, Najioullah F, Floret D. Role of Mycoplasma pneumoniae in pediatric encephalitis. Eur J Clin Microbiol Infect Dis. 2009;28(1):91-4.
Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clinical microbiology reviews. 2004;17(4):697-728, table of contents.
Zurynski Y, McIntyre P, Booy R, Elliott EJ, Group PI. Paediatric active enhanced disease surveillance: a new surveillance system for Australia. J Paediatr Child Health. 2013;49(7):588-94.
Britton PN, Dale RC, Elliott E, Festa M, Macartney K, Booy R, et al. Pilot surveillance for childhood encephalitis in Australia using the Paediatric Active Enhanced Disease Surveillance (PAEDS) network. Epidemiol Infect. 2016:1-11.
Sejvar JJ, Kohl KS, Bilynsky R, Blumberg D, Cvetkovich T, Galama J, et al. Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2007;25(31):5771-92. Epub 2007/06/16.
Venkatesan A, Tunkel AR, Bloch KC, Lauring AS, Sejvar J, Bitnun A, et al. Case Definitions, Diagnostic Algorithms, and Priorities in Encephalitis: Consensus Statement of the International Encephalitis Consortium. Clin Infect Dis. 2013. Epub 2013/07/19.
Muscatello DJ, Churches T, Kaldor J, Zheng W, Chiu C, Correll P, et al. An automated, broad-based, near real-time public health surveillance system using presentations to hospital Emergency Departments in New South Wales, Australia. BMC public health . 2005;5:141.
Classifications, International Classification of Diseases (ICD). In: Organization WH , editor. 2016.
Organisation IHTSD. SNOMED CT: The global language of healthcare. 2016.
Xue G, Wang Q, Yan C, Jeoffreys N, Wang L, Li S, et al. Molecular characterizations of PCR-positive Mycoplasma pneumoniae specimens collected from Australia and China. J Clin Microbiol. 2014;52(5):1478-82.
Othman N, Isaacs D, Kesson A. Mycoplasma pneumoniae infections in Australian children. J Paediatr Child Health. 2005;41(12):671-6.
Al-Zaidy SA, MacGregor D, Mahant S, Richardson SE, Bitnun A. Neurological Complications of PCR-Proven M. pneumoniae Infections in Children: Prodromal Illness Duration May Reflect Pathogenetic Mechanism. Clin Infect Dis. 2015;61(7):1092-8.
Kammer J, Ziesing S, Davila LA, Bultmann E, Illsinger S, Das AM, et al. Neurological Manifestations of Mycoplasma pneumoniae Infection in Hospitalized Children and Their Long-Term Follow-Up. Neuropediatrics. 2016.
Daxboeck F, Blacky A, Seidl R, Krause R, Assadian O. Diagnosis, treatment, and prognosis of Mycoplasma pneumoniae childhood encephalitis: systematic review of 58 cases. J Child Neurol. 2004;19(11):865-71.
Acworth J, Babl F, Borland M, Ngo P, Krieser D, Schutz J, et al. Patterns of presentation to the Australian and New Zealand Paediatric Emergency Research Network. Emergency medicine Australasia : EMA. 2009;21(1):59-66.
Wang K, Gill P, Perera R, Thomson A, Mant D, Harnden A. Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia. Cochrane Database of Systematic Reviews. 2012;10:CD009175.
Thurman KA, Walter ND, Schwartz SB, Mitchell SL, Dillon MT, Baughman AL, et al. Comparison of laboratory diagnostic procedures for detection of Mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48(9):1244-9.
Waites KB. What’s new in diagnostic testing and treatment approaches for Mycoplasma pneumoniae infections in children? Advances in Experimental Medicine & Biology. 2011;719:47-57.
Blix HS, Vestrheim DF, Hjellvik V, Skaare D, Christensen A, Steinbakk M. Antibiotic prescriptions and cycles of Mycoplasma pneumoniae infections in Norway: can a nationwide prescription register be used for surveillance? Epidemiol Infect. 2015;143(9):1884-92.
Walter ND, Grant GB, Bandy U, Alexander NE, Winchell JM, Jordan HT, et al. Community outbreak of Mycoplasma pneumoniae infection: school-based cluster of neurologic disease associated with household transmission of respiratory illness. J Infect Dis. 2008;198(9):1365-74.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2017 Communicable Diseases Intelligence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
